GR1006093B - Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης - Google Patents
Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασηςInfo
- Publication number
- GR1006093B GR1006093B GR20070100558A GR20070100558A GR1006093B GR 1006093 B GR1006093 B GR 1006093B GR 20070100558 A GR20070100558 A GR 20070100558A GR 20070100558 A GR20070100558 A GR 20070100558A GR 1006093 B GR1006093 B GR 1006093B
- Authority
- GR
- Greece
- Prior art keywords
- psoriasis
- preparation
- treatment
- medicinal product
- ursolic acid
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 4
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 title abstract 2
- 229940096998 ursolic acid Drugs 0.000 title abstract 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 abstract 3
- 206010037575 Pustular psoriasis Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241001529742 Rosmarinus Species 0.000 abstract 1
- 241001530490 Salvia rosmarinus Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002547 new drug Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000001050 pharmacotherapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Νέο φάρμακο για τη θεραπεία της ψωριάσεως με δραστικό συστατικό ουρσολικό οξύ (Ursolic acid), εξ απομονώσεως από το φυτό Rosmarinus officinalis (Δεντρολίβανο), και τα κατάλληλα έκδοχα για την παρασκευή αλοιφής. Με το σκεύασμα αυτό, τοπικής εφαρμογής, επιτυγχάνεται, χωρίς την εμφάνιση παρενεργειών, η πλήρης θεραπεία της νόσου, η οποία διατηρείται για μακρό χρονικό διάστημα, που τις περισσότερες φορές μετράται σε πολλά χρόνια. Υπάρχουν ασθενείς που έχουν συμπληρώσει πάνω απο 15 χρόνια από την ημέρα της πλήρους ίασης τους χωρίς να έχουν εμφανίσειυποτροπή. Ο χρόνος ίασης της ψωρίασης με το παρόνσκεύασμα εξαρτάται από διάφορους παράγοντες, με πιο σημαντικό τις προηγούμενες φαρμακοθεραπείες πουχρησιμοποίησε ο ασθενής. Το παρόν σκεύασμα με δραστικό συστατικό το ουρσολικό οξύ είναι αποτελεσματικό σε όλες τις κλινικές μορφές της ψωρίασης (μη φλυκταινώδης και φλυκταινώδης).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20070100558A GR1006093B (el) | 2007-09-07 | 2007-09-07 | Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20070100558A GR1006093B (el) | 2007-09-07 | 2007-09-07 | Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1006093B true GR1006093B (el) | 2008-10-06 |
Family
ID=39710830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20070100558A GR1006093B (el) | 2007-09-07 | 2007-09-07 | Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1006093B (el) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105832745A (zh) * | 2016-03-24 | 2016-08-10 | 新乡医学院 | Ursolic acid的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857554A (en) * | 1987-08-17 | 1989-08-15 | Georgios Kallimanis | Method for the treatment of psoriasis |
| WO1995017196A1 (en) * | 1993-12-21 | 1995-06-29 | Schering Corporation | Psoriasis treatment |
| US5811101A (en) * | 1997-04-29 | 1998-09-22 | Waltman Pharmaceuticals Incorporated | Composition for treating acne |
| US20060127513A1 (en) * | 2002-10-21 | 2006-06-15 | Tripp Matthew L | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
-
2007
- 2007-09-07 GR GR20070100558A patent/GR1006093B/el not_active IP Right Cessation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857554A (en) * | 1987-08-17 | 1989-08-15 | Georgios Kallimanis | Method for the treatment of psoriasis |
| WO1995017196A1 (en) * | 1993-12-21 | 1995-06-29 | Schering Corporation | Psoriasis treatment |
| US5811101A (en) * | 1997-04-29 | 1998-09-22 | Waltman Pharmaceuticals Incorporated | Composition for treating acne |
| US20060127513A1 (en) * | 2002-10-21 | 2006-06-15 | Tripp Matthew L | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
Non-Patent Citations (2)
| Title |
|---|
| AGGARWAL BHARAT B ET AL: "Suppression of the nuclear factor-kappa B activation pathway by spice-derived phytochemicals - Reasoning for seasoning", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, vol. 1030, 1 December 2004 (2004-12-01), pages 434 - 441, XP009097664, ISSN: 0077-8923 * |
| MASON J ET AL: "Topical preparations for the treatment of psoriasis: a systematic review", BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL PUBLISHING LTD, XX, vol. 146, no. 3, 1 March 2002 (2002-03-01), pages 351 - 364, XP002244836, ISSN: 0007-0963 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105832745A (zh) * | 2016-03-24 | 2016-08-10 | 新乡医学院 | Ursolic acid的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0720500A8 (pt) | Preparação líquida transdérmica | |
| Su et al. | Toona sinensis leaf extract has antinociceptive effect comparable with non-steroidal anti-inflammatory agents in mouse writhing test | |
| Sehhati Shaffaie et al. | Effect of the phenytoin cream on episiotomy healing in primipara women | |
| Gokul et al. | Plant-Based nanostructure for wound healing–An emerging paradigm for effective therapy | |
| Song et al. | Natural products-Dawn of keloid treatment | |
| CN103083500A (zh) | 一种治疗弓形虫病的中药组合物 | |
| Gandhi et al. | Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines | |
| GR1006093B (el) | Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης | |
| ATE535237T1 (de) | Verwendung von fts zur behandlung von malignen erkrankungen | |
| CN103041192B (zh) | 一种褥疮膏 | |
| CN103263425B (zh) | 磷霉素氨丁三醇在制备治疗慢性细菌性前列腺炎药物中的应用 | |
| CN107669735A (zh) | 一种治疗脚气外用药物及其制备方法 | |
| CN106334144A (zh) | 治疗皮肤病的外用药物 | |
| RU2501563C1 (ru) | Способ лечения локализованных форм псориаза | |
| CN103083473A (zh) | 一种治疗心脏病的药物及其制备方法 | |
| CN103585330B (zh) | 一种用于皮肤真菌感染的中药组合物及其制备方法 | |
| CN103341100A (zh) | 一种活血止痛抗炎消肿的药酒 | |
| CN103463611B (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
| CN107970419A (zh) | 治疗抑郁的中药组合物的制备方法 | |
| CN102283982B (zh) | 一种治疗体癣的药物组合物 | |
| Faisal et al. | Anti-inflammatory activity of Ethanolic extract of Cnicus Benedictus | |
| Chernykh et al. | Effect of phytoneering remedy BNO 2103 on the course of experimental exudative inflammation caused by different phlogogens | |
| CN100382835C (zh) | 手足癣消毒液 | |
| CN108929358A (zh) | 精氨酸甘草甜素及其制备方法和用途 | |
| CN104435491A (zh) | 一种用于治疗帕金森氏病的中药有效部位组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted | ||
| ML | Lapse due to non-payment of fees |
Effective date: 20150403 |